Erysipelas: Difference between revisions

	Erysipelas Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Erysipelas from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Erysipelas On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Erysipelas All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Erysipelas
CDC on Erysipelas
Erysipelas in the news
Blogs on Erysipelas
Directions to Hospitals Treating Erysipelas
Risk calculators and risk factors for Erysipelas

	Erysipelas;
	Erysipelas

Revision as of 17:09, 6 December 2012

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Non-necrotising cellulitis; acute bacterial dermohypodermatitis; erysipela

@@ Line 32: / Line 32: @@
 ==Treatment==
-[[Erysipelas medical therapy|Medical Therapy]] | [[Erysipelas surgery|Surgery]] | [[Erysipelas prevention|Prevention]] | [[Erysipelas cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Erysipelas future or investigational therapies|Future or Investigational Therapies]]
+[[Erysipelas medical therapy|Medical Therapy]] | [[Erysipelas prevention|Prevention]] | [[Erysipelas cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Erysipelas future or investigational therapies|Future or Investigational Therapies]]
 ==Case Studies==


Erysipelas
Erysipelas